Angiodynamics (ANGO) Depreciation & Amortization (CF) (2010 - 2026)

Angiodynamics (ANGO) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $5.6 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 11.52% year-over-year to $5.6 million; the trailing twelve-month figure through Feb 2026 stood at $23.2 million (down 13.41% YoY), and the FY2025 full-year result was $25.8 million, down 6.9% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $5.6 million, down from $5.7 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $7.8 million in Q1 2023 and bottomed at $5.6 million in Q1 2026.
• The 5-year median for Depreciation & Amortization (CF) is $6.8 million (2024), against an average of $6.9 million.
• The widest annual swing landed in 2022, when Depreciation & Amortization (CF) rose 17.52%; it then slipped 16.26% in 2025.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $7.8 million in 2022, then dropped by 14.49% to $6.7 million in 2023, then increased by 2.66% to $6.9 million in 2024, then dropped by 16.26% to $5.7 million in 2025, then dropped by 2.71% to $5.6 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $5.6 million (Q1 2026), $5.7 million (Q4 2025), and $6.0 million (Q3 2025), per Business Quant data.

Peer Comparison